Organization
Takara Bio
3 clinical trials
1 abstract
Clinical trial
A Multicenter Phase I/II Study for Relapsed or Refractory CD19+ B-acute Lymphoblastic LeukemiaStatus: Active (not recruiting), Estimated PCD: 2035-03-31
Clinical trial
Multi-center Phase I/II Study of NY-ESO-1 T Cell Receptor Gene Transferred T Lymphocytes in Patients With Synovial SarcomaStatus: Completed, Estimated PCD: 2020-01-23
Clinical trial
Phase I Study of Combination With TBI-1401(HF10), a Replication-competent HSV-1 Oncolytic Virus, and Chemotherapy in Patients With Stage III or IV Unresectable Pancreatic Cancer.Status: Active (not recruiting), Estimated PCD: 2020-02-19
Abstract
Results from phase I/II study of NY-ESO-1-specific TCR gene-transduced T cell therapy (TBI-1301, mipetresgene autoleucel) in patients with advanced synovial sarcoma.Org: National Cancer Center Hospital East, Kashiwa, Japan, Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, Mie University Hospital, Tsu, Japan, Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto-Shi, Japan, Mie University Graduate School of Medicine, Tsu, Japan,